“23andMe Inc., the Google Inc.-backed DNA analysis company co-founded by Anne Wojcicki, was told by U.S. regulators to halt sales of its main product because it’s being sold without ‘marketing clearance or approval.’ The Saliva Collection Kit and Personal Genome Service, or PGS, tells users whether they carry a disease, are at risk of a disease and would respond to a drug. Most of the uses fall into the category of a medical device and require Food and Drug Administration approval, the agency told the Mountain View, California-based company in a Nov. 22 letter made public today.”
(Visited 32 times, 1 visits today)
Related posts:
Oil and gas drillers use complex schemes to stiff retired landowners for royalties
Doctor returns Viet Cong soldier’s bone 40 years after amputation
The Middle East, explained in one (sort of terrifying) chart
FBI admits no major cases cracked with Patriot Act snooping powers
Police restrain crowd from taking food to be thrown away after supermarket eviction
Ron Paul: Secession Is 'Very American'
Commodities: High metal prices can put lives in danger
New York woman solves her father’s cold case murder 26 years later
Rich Chinese and Russians Flock to Germany to Spend
Steinway Agrees to Be Bought by Paulson for $512 Million
Japan equity mutual funds see large inflows on new tax-break scheme
Walmart tells India it can’t buy enough local products for new supermarket
Florida investment adviser charged with selling $8 million of fake Facebook shares
Youngest Bitcoin businessmen
Corzine, MF Global Will Face No Criminal Charges